Skip to main content
. 2019 Feb 13;14(2):e0211820. doi: 10.1371/journal.pone.0211820

Table 1. Baseline characteristics (N = 72,971).

Age, mean (SD), years 51.5 (9.6)
Male, n (%) 39,397 (54.0)
Baseline used diabetes medication classes, n (%)
     Metformin 53,017 (72.7)
     Sulfonylurea 25,439 (34.9)
     Dipeptidyl peptidase 4 inhibitor 8,540 (11.7)
     Glucagon-like peptide-1 receptor agonist 6,074 (8.3)
     Sodium glucose co-transporter inhibitor 1,133 (1.6)
     Thiazolidinedione 7,461 (10.2)